|  Help  |  About  |  Contact Us

Search our database by keyword

- or -

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 1 to 100 out of 155 for Mapkapk2

Category restricted to Publication (x)

<< First    < Previous  |  Next >    Last >>
0.047s

Categories

Category: Publication
« show all
Type Details Score
Publication
31070456 | J:291423
First Author: Tripathi D
Year: 2019
Journal: Arterioscler Thromb Vasc Biol
Title: Proinflammatory Effect of Endothelial Microparticles Is Mitochondria Mediated and Modulated Through MAPKAPK2 (MAPK-Activated Protein Kinase 2) Leading to Attenuation of Cardiac Hypertrophy.
Volume: 39
Issue: 6
Pages: 1100-1112
•
•
•
•
•
Publication
17481585 | J:122472
First Author: Wu Y
Year: 2007
Journal: Biochem Biophys Res Commun
Title: MAPKAPK2-mediated LSP1 phosphorylation and FMLP-induced neutrophil polarization.
Volume: 358
Issue: 1
Pages: 170-5
•
•
•
•
•
Publication
26280535 | J:227355
First Author: Herranz N
Year: 2015
Journal: Nat Cell Biol
Title: mTOR regulates MAPKAPK2 translation to control the senescence-associated secretory phenotype.
Volume: 17
Issue: 9
Pages: 1205-17
•
•
•
•
•
Publication
29844172 | J:262876
First Author: Henriques A
Year: 2018
Journal: Proc Natl Acad Sci U S A
Title: Mesenchymal MAPKAPK2/HSP27 drives intestinal carcinogenesis.
Volume: 115
Issue: 24
Pages: E5546-E5555
•
•
•
•
•
Publication
10559880 | J:59678
First Author: Kotlyarov A
Year: 1999
Journal: Nat Cell Biol
Title: MAPKAP kinase 2 is essential for LPS-induced TNF-alpha biosynthesis.
Volume: 1
Issue: 2
Pages: 94-7
•
•
•
•
•
Publication
9628873 | J:180499
First Author: Engel K
Year: 1998
Journal: EMBO J
Title: Leptomycin B-sensitive nuclear export of MAPKAP kinase 2 is regulated by phosphorylation.
Volume: 17
Issue: 12
Pages: 3363-71
•
•
•
•
•
Publication
18702688 | J:140579
First Author: Thomas T
Year: 2008
Journal: Eur J Neurosci
Title: MAP-kinase-activated protein kinase 2 expression and activity is induced after neuronal depolarization.
Volume: 28
Issue: 4
Pages: 642-54
•
•
•
•
•
Publication
36135933 | J:340738
First Author: Privitera L
Year: 2022
Journal: Aging Cell
Title: The MK2 cascade mediates transient alteration in mGluR-LTD and spatial learning in a murine model of Alzheimer's disease.
Volume: 21
Issue: 10
Pages: e13717
•
•
•
•
•
Publication
18987672 | J:150228
First Author: Funding AT
Year: 2009
Journal: J Invest Dermatol
Title: Reduced oxazolone-induced skin inflammation in MAPKAP kinase 2 knockout mice.
Volume: 129
Issue: 4
Pages: 891-8
•
•
•
•
•
Publication
17397860 | J:122434
First Author: Nagy N
Year: 2007
Journal: J Mol Cell Cardiol
Title: Ischemic preconditioning involves dual cardio-protective axes with p38MAPK as upstream target.
Volume: 42
Issue: 5
Pages: 981-90
•
•
•
•
•
Publication
16774924 | J:116517
First Author: Culbert AA
Year: 2006
Journal: J Biol Chem
Title: MAPK-activated protein kinase 2 deficiency in microglia inhibits pro-inflammatory mediator release and resultant neurotoxicity. Relevance to neuroinflammation in a transgenic mouse model of Alzheimer disease.
Volume: 281
Issue: 33
Pages: 23658-67
•
•
•
•
•
Publication
11564814 | J:118560
First Author: Hannigan MO
Year: 2001
Journal: J Immunol
Title: Abnormal migration phenotype of mitogen-activated protein kinase-activated protein kinase 2-/- neutrophils in Zigmond chambers containing formyl-methionyl-leucyl-phenylalanine gradients.
Volume: 167
Issue: 7
Pages: 3953-61
•
•
•
•
•
Publication
17600313 | J:141646
First Author: Liu T
Year: 2007
Journal: Am J Respir Cell Mol Biol
Title: Lack of MK2 inhibits myofibroblast formation and exacerbates pulmonary fibrosis.
Volume: 37
Issue: 5
Pages: 507-17
•
•
•
•
•
Publication
23657501 | J:205085
First Author: Mao X
Year: 2014
Journal: J Invest Dermatol
Title: MAPKAP kinase 2 (MK2)-dependent and -independent models of blister formation in pemphigus vulgaris.
Volume: 134
Issue: 1
Pages: 68-76
•
•
•
•
•
Publication
19609314 | J:159588
First Author: Thuraisingam T
Year: 2010
Journal: J Invest Dermatol
Title: MAPKAPK-2 signaling is critical for cutaneous wound healing.
Volume: 130
Issue: 1
Pages: 278-86
•
•
•
•
•
Publication
20943915 | J:165491
First Author: Ghasemlou N
Year: 2010
Journal: J Neurosci
Title: Mitogen-activated protein kinase-activated protein kinase 2 (MK2) contributes to secondary damage after spinal cord injury.
Volume: 30
Issue: 41
Pages: 13750-9
•
•
•
•
•
Publication
11971016 | J:76161
First Author: Lehner MD
Year: 2002
Journal: J Immunol
Title: Mitogen-activated protein kinase-activated protein kinase 2-deficient mice show increased susceptibility to Listeria monocytogenes infection.
Volume: 168
Issue: 9
Pages: 4667-73
•
•
•
•
•
Publication
27795356 | J:328774
 
First Author: Herbert BA
Year: 2017
Journal: Infect Immun
Title: Mitogen-Activated Protein Kinase 2 Signaling Shapes Macrophage Plasticity in Aggregatibacter actinomycetemcomitans-Induced Bone Loss.
Volume: 85
Issue: 1
•
•
•
•
•
Publication
16849504 | J:138360
First Author: Hegen M
Year: 2006
Journal: J Immunol
Title: MAPKAP kinase 2-deficient mice are resistant to collagen-induced arthritis.
Volume: 177
Issue: 3
Pages: 1913-7
•
•
•
•
•
Publication
26431421 | J:243529
First Author: Limbourg A
Year: 2015
Journal: PLoS One
Title: MAP-Kinase Activated Protein Kinase 2 Links Endothelial Activation and Monocyte/macrophage Recruitment in Arteriogenesis.
Volume: 10
Issue: 10
Pages: e0138542
•
•
•
•
•
Publication
25946081 | J:235349
First Author: Herbert BA
Year: 2015
Journal: PLoS One
Title: Sexual Dimorphism in MAPK-Activated Protein Kinase-2 (MK2) Regulation of RANKL-Induced Osteoclastogenesis in Osteoclast Progenitor Subpopulations.
Volume: 10
Issue: 5
Pages: e0125387
•
•
•
•
•
Publication
26238259 | J:227929
First Author: Ray AL
Year: 2016
Journal: Int J Cancer
Title: Blockade of MK2 is protective in inflammation-associated colorectal cancer development.
Volume: 138
Issue: 3
Pages: 770-5
•
•
•
•
•
Publication
26558681 | J:250461
First Author: Ruiz M
Year: 2016
Journal: Diabetes
Title: MK2 Deletion in Mice Prevents Diabetes-Induced Perturbations in Lipid Metabolism and Cardiac Dysfunction.
Volume: 65
Issue: 2
Pages: 381-92
•
•
•
•
•
Publication
15623425 | J:101888
First Author: Shiroto K
Year: 2005
Journal: J Mol Cell Cardiol
Title: MK2-/- gene knockout mouse hearts carry anti-apoptotic signal and are resistant to ischemia reperfusion injury.
Volume: 38
Issue: 1
Pages: 93-7
•
•
•
•
•
Publication
25233471 | J:222510
First Author: de Boer JF
Year: 2014
Journal: PLoS One
Title: Mitogen-activated protein kinase-activated protein kinase 2 deficiency reduces insulin sensitivity in high-fat diet-fed mice.
Volume: 9
Issue: 9
Pages: e106300
•
•
•
•
•
Publication
19244108 | J:145952
First Author: Bouska A
Year: 2009
Journal: Cancer Res
Title: Mdm2 affects genome stability independent of p53.
Volume: 69
Issue: 5
Pages: 1697-701
•
•
•
•
•
Publication
28924177 | J:288130
First Author: Soukup K
Year: 2017
Journal: Sci Rep
Title: Loss of MAPK-activated protein kinase 2 enables potent dendritic cell-driven anti-tumour T cell response.
Volume: 7
Issue: 1
Pages: 11746
•
•
•
•
•
Publication
20596525 | J:162007
First Author: Yuan J
Year: 2010
Journal: PLoS One
Title: MAPK-activated protein kinase 2 is required for mouse meiotic spindle assembly and kinetochore-microtubule attachment.
Volume: 5
Issue: 6
Pages: e11247
•
•
•
•
•
Publication
23220022 | J:205613
First Author: Noguchi N
Year: 2013
Journal: Arch Biochem Biophys
Title: Phosphorylation of epidermal growth factor receptor at serine 1047 by MAP kinase-activated protein kinase-2 in cultured lung epithelial cells treated with flagellin.
Volume: 529
Issue: 2
Pages: 75-85
•
•
•
•
•
Publication
29197088 | J:257865
First Author: Ray AL
Year: 2018
Journal: Int J Cancer
Title: Inhibition of MK2 suppresses IL-1β, IL-6, and TNF-α-dependent colorectal cancer growth.
Volume: 142
Issue: 8
Pages: 1702-1711
•
•
•
•
•
Publication
30275345 | J:268002
 
First Author: Fan W
Year: 2018
Journal: Mol Cell Biol
Title: Hsp70 Interacts with Mitogen-Activated Protein Kinase (MAPK)-Activated Protein Kinase 2 To Regulate p38MAPK Stability and Myoblast Differentiation during Skeletal Muscle Regeneration.
Volume: 38
Issue: 24
•
•
•
•
•
Publication
8262198 | J:20645
First Author: Engel K
Year: 1993
Journal: FEBS Lett
Title: The MAP kinase-activated protein kinase 2 contains a proline-rich SH3-binding domain.
Volume: 336
Issue: 1
Pages: 143-7
•
•
•
•
•
Publication
12456657 | J:180488
First Author: Rousseau S
Year: 2002
Journal: EMBO J
Title: Inhibition of SAPK2a/p38 prevents hnRNP A0 phosphorylation by MAPKAP-K2 and its interaction with cytokine mRNAs.
Volume: 21
Issue: 23
Pages: 6505-14
•
•
•
•
•
Publication
12052889 | J:112157
First Author: Kotlyarov A
Year: 2002
Journal: Mol Cell Biol
Title: Distinct cellular functions of MK2.
Volume: 22
Issue: 13
Pages: 4827-35
•
•
•
•
•
Publication
14688255 | J:200320
First Author: Chrestensen CA
Year: 2004
Journal: J Biol Chem
Title: MAPKAP kinase 2 phosphorylates tristetraprolin on in vivo sites including Ser178, a site required for 14-3-3 binding.
Volume: 279
Issue: 11
Pages: 10176-84
•
•
•
•
•
Publication
14560018 | J:86268
First Author: Shi Y
Year: 2003
Journal: Mol Cell Biol
Title: Elimination of protein kinase MK5/PRAK activity by targeted homologous recombination.
Volume: 23
Issue: 21
Pages: 7732-41
•
•
•
•
•
Publication
28931551 | J:262524
First Author: Reboll MR
Year: 2017
Journal: Circulation
Title: EMC10 (Endoplasmic Reticulum Membrane Protein Complex Subunit 10) Is a Bone Marrow-Derived Angiogenic Growth Factor Promoting Tissue Repair After Myocardial Infarction.
Volume: 136
Issue: 19
Pages: 1809-1823
•
•
•
•
•
Publication
31167133 | J:289879
First Author: Trulley P
Year: 2019
Journal: Cell Rep
Title: Alternative Translation Initiation Generates a Functionally Distinct Isoform of the Stress-Activated Protein Kinase MK2.
Volume: 27
Issue: 10
Pages: 2859-2870.e6
•
•
•
•
•
Publication
34999110 | J:341285
 
First Author: Thirunavukkarasu M
Year: 2022
Journal: Microvasc Res
Title: Gene therapy with Pellino-1 improves perfusion and decreases tissue loss in Flk-1 heterozygous mice but fails in MAPKAP Kinase-2 knockout murine hind limb ischemia model.
Volume: 141
Pages: 104311
•
•
•
•
•
Publication
37415974 | J:337739
 
First Author: Jacenik D
Year: 2023
Journal: Front Immunol
Title: MK2 drives progression of pancreas and colon cancers by suppressing CD8(+) T cell cytotoxic function and is a potential immunotherapy target.
Volume: 14
Pages: 1212100
•
•
•
•
•
Publication
33708191 | J:314012
 
First Author: Suarez-Lopez L
Year: 2020
Journal: Front Immunol
Title: MAPKAP Kinase-2 Drives Expression of Angiogenic Factors by Tumor-Associated Macrophages in a Model of Inflammation-Induced Colon Cancer.
Volume: 11
Pages: 607891
•
•
•
•
•
Publication
29770701 | J:264576
First Author: Wu Y
Year: 2018
Journal: Am J Physiol Lung Cell Mol Physiol
Title: MK2 mediates macrophage activation and acute lung injury by regulating let-7e miRNA.
Volume: 315
Issue: 3
Pages: L371-L381
•
•
•
•
•
Publication
24082115 | J:201996
First Author: Köpper F
Year: 2013
Journal: Proc Natl Acad Sci U S A
Title: Damage-induced DNA replication stalling relies on MAPK-activated protein kinase 2 activity.
Volume: 110
Issue: 42
Pages: 16856-61
•
•
•
•
•
Publication
23139224 | J:194690
First Author: Michler T
Year: 2013
Journal: Am J Physiol Gastrointest Liver Physiol
Title: Activation of cannabinoid receptor 2 reduces inflammation in acute experimental pancreatitis via intra-acinar activation of p38 and MK2-dependent mechanisms.
Volume: 304
Issue: 2
Pages: G181-92
•
•
•
•
•
Publication
23372691 | J:195922
First Author: Guess AJ
Year: 2013
Journal: PLoS One
Title: Crucial roles of the protein kinases MK2 and MK3 in a mouse model of glomerulonephritis.
Volume: 8
Issue: 1
Pages: e54239
•
•
•
•
•
Publication
19657354 | J:159580
First Author: Schottelius AJ
Year: 2010
Journal: J Invest Dermatol
Title: The role of mitogen-activated protein kinase-activated protein kinase 2 in the p38/TNF-alpha pathway of systemic and cutaneous inflammation.
Volume: 130
Issue: 2
Pages: 481-91
•
•
•
•
•
Publication
24304496 | J:232083
First Author: Damarla M
Year: 2014
Journal: Am J Respir Cell Mol Biol
Title: Mitogen-activated protein kinase-activated protein kinase 2 mediates apoptosis during lung vascular permeability by regulating movement of cleaved caspase 3.
Volume: 50
Issue: 5
Pages: 932-41
•
•
•
•
•
Publication
29187369 | J:283129
First Author: Nie X
Year: 2018
Journal: Am J Physiol Renal Physiol
Title: Pharmacological and genetic inhibition of downstream targets of p38 MAPK in experimental nephrotic syndrome.
Volume: 314
Issue: 4
Pages: F602-F613
•
•
•
•
•
Publication
27974048 | J:285085
First Author: Maphis N
Year: 2016
Journal: Alzheimers Res Ther
Title: Selective suppression of the α isoform of p38 MAPK rescues late-stage tau pathology.
Volume: 8
Issue: 1
Pages: 54
•
•
•
•
•
Publication
23381627 | J:194316
First Author: Li YY
Year: 2013
Journal: Lab Invest
Title: Inhibition of p38/Mk2 signaling pathway improves the anti-inflammatory effect of WIN55 on mouse experimental colitis.
Volume: 93
Issue: 3
Pages: 322-33
•
•
•
•
•
Publication
19359247 | J:150687
First Author: Zhu J
Year: 2009
Journal: J Biol Chem
Title: MAPK-activated protein kinase 2 differentially regulates plasmodium falciparum glycosylphosphatidylinositol-induced production of tumor necrosis factor-{alpha} and interleukin-12 in macrophages.
Volume: 284
Issue: 23
Pages: 15750-61
•
•
•
•
•
Publication
26078274 | J:238250
First Author: Soukup K
Year: 2015
Journal: J Immunol
Title: The MAPK-Activated Kinase MK2 Attenuates Dendritic Cell-Mediated Th1 Differentiation and Autoimmune Encephalomyelitis.
Volume: 195
Issue: 2
Pages: 541-52
•
•
•
•
•
Publication
8093038 | J:20329
First Author: Plath K
Year: 1994
Journal: Biochem Biophys Res Commun
Title: Characterization of the proline-rich region of mouse MAPKAP kinase 2: influence on catalytic properties and binding to the c-abl SH3 domain in vitro.
Volume: 203
Issue: 2
Pages: 1188-94
•
•
•
•
•
Publication
23202365 | J:216910
First Author: Heo KS
Year: 2013
Journal: Arterioscler Thromb Vasc Biol
Title: Phosphorylation of protein inhibitor of activated STAT1 (PIAS1) by MAPK-activated protein kinase-2 inhibits endothelial inflammation via increasing both PIAS1 transrepression and SUMO E3 ligase activity.
Volume: 33
Issue: 2
Pages: 321-9
•
•
•
•
•
Publication
24935968 | J:217839
First Author: Köther K
Year: 2014
Journal: FASEB J
Title: MAPKAP kinase 3 suppresses Ifng gene expression and attenuates NK cell cytotoxicity and Th1 CD4 T-cell development upon influenza A virus infection.
Volume: 28
Issue: 10
Pages: 4235-46
•
•
•
•
•
Publication
28920952 | J:246659
First Author: Dondelinger Y
Year: 2017
Journal: Nat Cell Biol
Title: MK2 phosphorylation of RIPK1 regulates TNF-mediated cell death.
Volume: 19
Issue: 10
Pages: 1237-1247
•
•
•
•
•
Publication
29666270 | J:261657
First Author: Suarez-Lopez L
Year: 2018
Journal: Proc Natl Acad Sci U S A
Title: MK2 contributes to tumor progression by promoting M2 macrophage polarization and tumor angiogenesis.
Volume: 115
Issue: 18
Pages: E4236-E4244
•
•
•
•
•
Publication
25132469 | J:221542
First Author: Kroner A
Year: 2014
Journal: Neuron
Title: TNF and increased intracellular iron alter macrophage polarization to a detrimental M1 phenotype in the injured spinal cord.
Volume: 83
Issue: 5
Pages: 1098-116
•
•
•
•
•
Publication
24964076 | J:216820
First Author: Tietz SM
Year: 2014
Journal: PLoS One
Title: MK2 and Fas receptor contribute to the severity of CNS demyelination.
Volume: 9
Issue: 6
Pages: e100363
•
•
•
•
•
Publication
17485113 | J:123570
First Author: Thuraisingam T
Year: 2007
Journal: Mol Immunol
Title: Distinct role of MAPKAPK-2 in the regulation of TNF gene expression by Toll-like receptor 7 and 9 ligands.
Volume: 44
Issue: 14
Pages: 3482-91
•
•
•
•
•
Publication
30048492 | J:267794
First Author: Rao GK
Year: 2018
Journal: PLoS One
Title: T cell LFA-1-induced proinflammatory mRNA stabilization is mediated by the p38 pathway kinase MK2 in a process regulated by hnRNPs C, H1 and K.
Volume: 13
Issue: 7
Pages: e0201103
•
•
•
•
•
Publication
11741878 | J:74321
First Author: Neininger A
Year: 2002
Journal: J Biol Chem
Title: MK2 targets AU-rich elements and regulates biosynthesis of tumor necrosis factor and interleukin-6 independently at different post-transcriptional levels.
Volume: 277
Issue: 5
Pages: 3065-8
•
•
•
•
•
Publication
17312125 | J:144113
First Author: Ehlting C
Year: 2007
Journal: J Immunol
Title: Regulation of suppressor of cytokine signaling 3 (SOCS3) mRNA stability by TNF-alpha involves activation of the MKK6/p38MAPK/MK2 cascade.
Volume: 178
Issue: 5
Pages: 2813-26
•
•
•
•
•
Publication
20724476 | J:166791
First Author: Menon MB
Year: 2010
Journal: J Biol Chem
Title: p38 MAP kinase and MAPKAP kinases MK2/3 cooperatively phosphorylate epithelial keratins.
Volume: 285
Issue: 43
Pages: 33242-51
•
•
•
•
•
Publication
20595389 | J:235259
First Author: Marchese FP
Year: 2010
Journal: J Biol Chem
Title: MAPKAP kinase 2 blocks tristetraprolin-directed mRNA decay by inhibiting CAF1 deadenylase recruitment.
Volume: 285
Issue: 36
Pages: 27590-600
•
•
•
•
•
Publication
26068544 | J:246632
First Author: Ozcan L
Year: 2015
Journal: Diabetes
Title: Treatment of Obese Insulin-Resistant Mice With an Allosteric MAPKAPK2/3 Inhibitor Lowers Blood Glucose and Improves Insulin Sensitivity.
Volume: 64
Issue: 10
Pages: 3396-405
•
•
•
•
•
Publication
17885219 | J:142788
First Author: Jagavelu K
Year: 2007
Journal: Circ Res
Title: Systemic deficiency of the MAP kinase-activated protein kinase 2 reduces atherosclerosis in hypercholesterolemic mice.
Volume: 101
Issue: 11
Pages: 1104-12
•
•
•
•
•
Publication
19808857 | J:155222
First Author: Johansen C
Year: 2009
Journal: Carcinogenesis
Title: MK2 regulates the early stages of skin tumor promotion.
Volume: 30
Issue: 12
Pages: 2100-8
•
•
•
•
•
Publication
23608535 | J:204489
First Author: Scharf M
Year: 2013
Journal: Mol Cell Biol
Title: Mitogen-activated protein kinase-activated protein kinases 2 and 3 regulate SERCA2a expression and fiber type composition to modulate skeletal muscle and cardiomyocyte function.
Volume: 33
Issue: 13
Pages: 2586-602
•
•
•
•
•
Publication
25134715 | J:272427
 
First Author: Eales KL
Year: 2014
Journal: Nat Commun
Title: The MK2/3 cascade regulates AMPAR trafficking and cognitive flexibility.
Volume: 5
Pages: 4701
•
•
•
•
•
Publication
20339119 | J:172141
First Author: Streicher JM
Year: 2010
Journal: Circ Res
Title: MAPK-activated protein kinase-2 in cardiac hypertrophy and cyclooxygenase-2 regulation in heart.
Volume: 106
Issue: 8
Pages: 1434-43
•
•
•
•
•
Publication
17576778 | J:125870
First Author: Gorska MM
Year: 2007
Journal: J Exp Med
Title: MK2 controls the level of negative feedback in the NF-kappaB pathway and is essential for vascular permeability and airway inflammation.
Volume: 204
Issue: 7
Pages: 1637-52
•
•
•
•
•
Publication
34633746 | J:318691
First Author: Chen IT
Year: 2021
Journal: EMBO Rep
Title: Promyelocytic leukemia protein targets MK2 to promote cytotoxicity.
Volume: 22
Issue: 12
Pages: e52254
•
•
•
•
•
Publication
15538386 | J:94780
First Author: Schumacher S
Year: 2004
Journal: EMBO J
Title: Scaffolding by ERK3 regulates MK5 in development.
Volume: 23
Issue: 24
Pages: 4770-9
•
•
•
•
•
Publication
17906627 | J:126340
First Author: Zaru R
Year: 2007
Journal: Nat Immunol
Title: The MAPK-activated kinase Rsk controls an acute Toll-like receptor signaling response in dendritic cells and is activated through two distinct pathways.
Volume: 8
Issue: 11
Pages: 1227-35
•
•
•
•
•
Publication
16508014 | J:106919
First Author: Hitti E
Year: 2006
Journal: Mol Cell Biol
Title: Mitogen-activated protein kinase-activated protein kinase 2 regulates tumor necrosis factor mRNA stability and translation mainly by altering tristetraprolin expression, stability, and binding to adenine/uridine-rich element.
Volume: 26
Issue: 6
Pages: 2399-407
•
•
•
•
•
Publication
24239348 | J:203686
First Author: Morandell S
Year: 2013
Journal: Cell Rep
Title: A reversible gene-targeting strategy identifies synthetic lethal interactions between MK2 and p53 in the DNA damage response in vivo.
Volume: 5
Issue: 4
Pages: 868-77
•
•
•
•
•
Publication
28011639 | J:240712
First Author: Hayakawa M
Year: 2017
Journal: J Biol Chem
Title: Loss of Functionally Redundant p38 Isoforms in T Cells Enhances Regulatory T Cell Induction.
Volume: 292
Issue: 5
Pages: 1762-1772
•
•
•
•
•
Publication
33427298 | J:319427
First Author: Drube S
Year: 2021
Journal: Immunology
Title: IL-3 is essential for ICOS-L stabilization on mast cells, and sustains the IL-33-induced RORγt+ Treg generation via enhanced IL-6 induction.
Volume: 163
Issue: 1
Pages: 86-97
•
•
•
•
•
Publication
26859455 | J:231452
First Author: Lalaoui N
Year: 2016
Journal: Cancer Cell
Title: Targeting p38 or MK2 Enhances the Anti-Leukemic Activity of Smac-Mimetics.
Volume: 29
Issue: 2
Pages: 145-58
•
•
•
•
•
Publication
16423921 | J:111093
First Author: Tietz AB
Year: 2006
Journal: Am J Physiol Gastrointest Liver Physiol
Title: Gene deletion of MK2 inhibits TNF-alpha and IL-6 and protects against cerulein-induced pancreatitis.
Volume: 290
Issue: 6
Pages: G1298-306
•
•
•
•
•
Publication
20375303 | J:161009
First Author: Gais P
Year: 2010
Journal: J Immunol
Title: TRIF signaling stimulates translation of TNF-alpha mRNA via prolonged activation of MK2.
Volume: 184
Issue: 10
Pages: 5842-8
•
•
•
•
•
Publication
31527197 | J:280867
First Author: Ronkina N
Year: 2019
Journal: J Immunol
Title: The Role of TTP Phosphorylation in the Regulation of Inflammatory Cytokine Production by MK2/3.
Volume: 203
Issue: 8
Pages: 2291-2300
•
•
•
•
•
Publication
16199873 | J:101350
First Author: Abell AN
Year: 2005
Journal: Mol Cell Biol
Title: Ablation of MEKK4 kinase activity causes neurulation and skeletal patterning defects in the mouse embryo.
Volume: 25
Issue: 20
Pages: 8948-59
•
•
•
•
•
Publication
24020373 | J:204512
First Author: Menon MB
Year: 2013
Journal: Biochem J
Title: Endoplasmic reticulum-associated ubiquitin-conjugating enzyme Ube2j1 is a novel substrate of MK2 (MAPKAP kinase-2) involved in MK2-mediated TNFα production.
Volume: 456
Issue: 2
Pages: 163-72
•
•
•
•
•
Publication
20212154 | J:158685
First Author: Cannell IG
Year: 2010
Journal: Proc Natl Acad Sci U S A
Title: p38 MAPK/MK2-mediated induction of miR-34c following DNA damage prevents Myc-dependent DNA replication.
Volume: 107
Issue: 12
Pages: 5375-80
•
•
•
•
•
Publication
19240800 | J:145960
First Author: Damarla M
Year: 2009
Journal: PLoS One
Title: Mitogen activated protein kinase activated protein kinase 2 regulates actin polymerization and vascular leak in ventilator associated lung injury.
Volume: 4
Issue: 2
Pages: e4600
•
•
•
•
•
Publication
20200229 | J:158710
First Author: Radtke S
Year: 2010
Journal: J Cell Sci
Title: Cross-regulation of cytokine signalling: pro-inflammatory cytokines restrict IL-6 signalling through receptor internalisation and degradation.
Volume: 123
Issue: Pt 6
Pages: 947-59
•
•
•
•
•
Publication
22345171 | J:196935
First Author: Jagielska J
Year: 2012
Journal: Arterioscler Thromb Vasc Biol
Title: Interleukin-1 assembles a proangiogenic signaling module consisting of caveolin-1, tumor necrosis factor receptor-associated factor 6, p38-mitogen-activated protein kinase (MAPK), and MAPK-activated protein kinase 2 in endothelial cells.
Volume: 32
Issue: 5
Pages: 1280-8
•
•
•
•
•
Publication
28506461 | J:251943
First Author: Jaco I
Year: 2017
Journal: Mol Cell
Title: MK2 Phosphorylates RIPK1 to Prevent TNF-Induced Cell Death.
Volume: 66
Issue: 5
Pages: 698-710.e5
•
•
•
•
•
Publication
33983975 | J:307341
First Author: Ozcan L
Year: 2021
Journal: PLoS One
Title: Allosteric MAPKAPK2 inhibitors improve plaque stability in advanced atherosclerosis.
Volume: 16
Issue: 5
Pages: e0246600
•
•
•
•
•
Publication
17030606 | J:117668
First Author: Ronkina N
Year: 2007
Journal: Mol Cell Biol
Title: The mitogen-activated protein kinase (MAPK)-activated protein kinases MK2 and MK3 cooperate in stimulation of tumor necrosis factor biosynthesis and stabilization of p38 MAPK.
Volume: 27
Issue: 1
Pages: 170-81
•
•
•
•
•
Publication
11447117 | J:108402
First Author: Kontoyiannis D
Year: 2001
Journal: EMBO J
Title: Interleukin-10 targets p38 MAPK to modulate ARE-dependent TNF mRNA translation and limit intestinal pathology.
Volume: 20
Issue: 14
Pages: 3760-70
•
•
•
•
•
Publication
28920954 | J:246735
First Author: Menon MB
Year: 2017
Journal: Nat Cell Biol
Title: p38MAPK/MK2-dependent phosphorylation controls cytotoxic RIPK1 signalling in inflammation and infection.
Volume: 19
Issue: 10
Pages: 1248-1259
•
•
•
•
•
Publication
29288203 | J:258126
First Author: Göpfert C
Year: 2018
Journal: J Immunol
Title: The p38-MK2/3 Module Is Critical for IL-33-Induced Signaling and Cytokine Production in Dendritic Cells.
Volume: 200
Issue: 3
Pages: 1198-1206
•
•
•
•
•
Publication
19369945 | J:148784
First Author: Schwermann J
Year: 2009
Journal: EMBO J
Title: MAPKAP kinase MK2 maintains self-renewal capacity of haematopoietic stem cells.
Volume: 28
Issue: 10
Pages: 1392-406
•
•
•
•
•
Publication
32094226 | J:286820
First Author: Ariana A
Year: 2020
Journal: J Biol Chem
Title: Tristetraprolin regulates necroptosis during tonic Toll-like receptor 4 (TLR4) signaling in murine macrophages.
Volume: 295
Issue: 14
Pages: 4661-4672
•
•
•
•
•
Publication
19224920 | J:149257
First Author: Mikkelsen SS
Year: 2009
Journal: J Biol Chem
Title: RIG-I-mediated activation of p38 MAPK is essential for viral induction of interferon and activation of dendritic cells: dependence on TRAF2 and TAK1.
Volume: 284
Issue: 16
Pages: 10774-82
•
•
•
•
•
Publication
32424229 | J:298448
First Author: Helbig C
Year: 2020
Journal: Sci Rep
Title: The IL-33-induced p38-/JNK1/2-TNFα axis is antagonized by activation of β-adrenergic-receptors in dendritic cells.
Volume: 10
Issue: 1
Pages: 8152
•
•
•
•
•
Publication
29229781 | J:258440
First Author: Sutavani RV
Year: 2018
Journal: J Biol Chem
Title: Differential control of Toll-like receptor 4-induced interleukin-10 induction in macrophages and B cells reveals a role for p90 ribosomal S6 kinases.
Volume: 293
Issue: 7
Pages: 2302-2317
•
•
•
•
•




MouseMine is a collaboration between MGI at The Jackson Laboratory and the InterMine project at the Cambridge Systems Biology Centre. MouseMine is funded through a grant from the NIH/NHGRI.The Jackson Laboratory makes no representation about the suitability or accuracy of this software or data for any purpose, and makes no warranties, either express or implied, including merchantability and fitness for a particular purpose or that the use of this software or data will not infringe any third party patents, copyrights, trademarks, or other rights. the software and data are provided "as is". This software and data are provided to enhance knowledge and encourage progress in the scientific community and are to be used only for research and educational purposes. Any reproduction or use for commercial purpose is prohibited without the prior express written permission of the Jackson Laboratory.

Copyright © 2017 by The Jackson Laboratory. All Rights Reserved

© 2002 - 2017 Department of Genetics, University of Cambridge, Downing Street,
Cambridge CB2 3EH, United Kingdom